Dietary pulp from Fructus Schisandra Chinensis supplementation reduces serum/hepatic lipid and hepatic glucose levels in mice fed a normal or high cholesterol/bile salt diet

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Sun, Nan ^a   Pan, Si Yuan ^a   Zhang, Yi ^a   Wang, Xiao Yan ^a   Zhu, Pei Li ^a   Chu, Zhu Sheng ^a   Yu, Zhi Ling ^b   Zhou, Shu Feng ^c   Ko, Kam Ming ^d  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Bicyclol; Epididymal fat; Fatty liver; Fructus Schisandrae Chinensis; Glucose; Hypercholesterolemia

Indexed keywords

ALANINE AMINOTRANSFERASE; BILE SALT; CHOLESTEROL; GLUCOSE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN; LIPID; LIVER PROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; FRUCTUS SCHISANDRA CHINENSIS PLANT EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FRUIT; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; SCHISANDRA CHINENSIS; SUPERNATANT; WEIGHT GAIN; FATTY LIVER; FOOD INTAKE; GLUCOSE LIVER LEVEL; HYPERTRIGLYCERIDEMIA; LIVER LEVEL; LIVER WEIGHT; OBESITY;

ADIPOSITY; ANIMALS; ANTICHOLESTEREMIC AGENTS; BILE ACIDS AND SALTS; BIPHENYL COMPOUNDS; BLOOD GLUCOSE; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; HYPERCHOLESTEROLEMIA; LIVER; MALE; MICE; MICE, INBRED ICR; SCHISANDRA; TRIGLYCERIDES; WEIGHT GAIN;

MUS; SCHISANDRA CHINENSIS;

EID: 84899058405     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-46     Document Type: Article

References (40)

1. Hyperlipidemia as a risk factor for cardiovascular disease. Nelson RH, Prim Care 2013 40 1 195 211 10.1016/j.pop.2012.11.003 23402469
2. Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies. Liu J, Zeng FF, Liu ZM, Zhang CX, Ling WH, Chen YM, Lipids Health Dis 2013 doi:10.1186/1476-511X-12-159
3. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Vernon G, Baranova A, Younossi ZM, Aliment Pharmacol Ther 2011 34 3 274 285 10.1111/j.1365-2036.2011.04724.x 21623852
4. Circulatory syndrome: an evolution of the metabolic syndrome concept! Khoshdel AR, Carney SL, Gillies A, Curr Cardiol Rev 2012 8 1 68 76 10.2174/157340312801215773 22845817
5. Biomedicine & diseases: review lipid lowering drugs. Pahan K, Cell Mol Life Sci 2006 63 1165 1178 10.1007/s00018-005-5406-7 16568248
6. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population. Amend KL, Landon J, Thyagarajan V, Niemcryk S, McAfee A, Ann Pharmacother 2011 45 10 1230 1239 10.1345/aph.1Q110 21917557
7. Pharmacoepidemiology safety study of fibrate and statin concomitant therapy. Enger C, Gately R, Ming EE, Niemcryk SJ, Williams L, McAfee AT, Am J Cardiol 2010 106 11 1594 1601 10.1016/j.amjcard.2010.07.041 21094360
8. Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Potgieter M, Pretorius E, Pepper MS, Nutr Rev 2013 71 3 180 188 10.1111/nure.12011 23452285
9. The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis. Scholle JM, Baker WL, Talati R, Coleman CI, J Am Coll Nutr 2009 28 5 517 524 10.1080/07315724.2009.10719784 20439548
10. Semen quality and sperm function loss by hypercholesterolemic diet was recovered by addition of olive oil to diet in rabbit. Saez Lancellotti TE, Boarelli PV, Romero AA, Funes AK, Cid-Barria M, Cabrillana ME, Monclus MA, Simón L, Vicenti AE, Fornés MW, PLoS One 2013 8 1 52386 10.1371/journal.pone.0052386 23326331
11. Regulation of lipid metabolism-related gene expression in whole blood cells of normo- and dyslipidemic men after fish oil supplementation. Schmidt S, Willers J, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt JP, Lipids Health Dis 2012 doi:10.1186/1476-511X-11-172
12. Effect of supplementation of probiotics and phytosterols alone or in combination on serum and hepatic lipid profiles and thyroid hormones of hypercholesterolemic rats. Awaisheh SS, Khalifeh MS, Al-Ruwaili MA, Khalil OM, Al-Ameri OH, Al-Groom R, J Dairy Sci 2013 96 1 9 15 10.3168/jds.2012-5442 23182355
13. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia: a systematic review. Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M, Curr Pharm Des 2010 16 26 2935 2940 10.2174/138161210793176464 20858178
14. Ayurvedic and collateral herbal treatments for hyperlipidemia: a systematic review of randomized controlled trials and quasi-experimental designs. Singh BB, Vinjamury SP, Der-Martirosian C, Kubik E, Mishra LC, Shepard NP, Singh VJ, Meier M, Madhu SG, Altern Ther Health Med 2007 13 4 22 28
15. Dietary fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity. Pan SY, Yu Q, Zhang Y, Wang XY, Sun N, Yu ZL, Ko KM, Lipids Health Dis 2012 doi:10.1186/1476-511X-11-120
16. Ethanol extract of Fructus Schisandrae decreases hepatic triglyceride level in mice fed with a high fat/cholesterol diet, with attention to acute toxicity. Pan SY, Yu ZL, Dong H, Xiang CJ, Fong WF, Ko KM, Evid Based Complement Alternat Med 2011 doi:10.1093/ecam/nep070
17. Schisandrin B from Schisandra chinensis reduce hepatic lipid contents in hypercholesterolaemic mice. Pan SY, Dong H, Zhao XY, Xiang CJ, Fang HY, Fong WF, Yu ZL, Ko KM, J Pharm Pharmacol 2008 60 3 399 403 10.1211/jpp.60.3.0017 18284822
18. Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice. Pan SY, Dong H, Yu ZL, Zhao XY, Xiang CJ, Wang H, Fong WF, Ko KM, J Pharm Pharmacol 2007 59 12 1657 1662 10.1211/jpp.59.12.0007 18053327
19. Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice. Pan SY, Yang R, Dong H, Yu ZL, Ko KM, Eur J Pharmacol 2006 552 1-3 170 177 17046746
20. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Robinson JG, J Manag Care Pharm 2013 19 2 139 149 23461430
21. The clinical investigation of disparity of nonalcoholic fatty liver disease in a Chinese occupational population in Taipei, Taiwan: experience at a teaching hospital. Wang J, Chiu WH, Chen RC, Chen FL, Tung TH, Asia Pac J Public Health 2013 doi:10.1177/1010539513483830
22. Anti-atherogenic effects of a new thienylacylhydrazone derivative, LASSBio-788, in rats fed a hypercholesterolemic diet. da Motta NA V, Kümmerle AE, Marostica E, Fernandes Dos Santos C, Manssour Fraga CA, Barreiro EJ, de Miranda AL, de Brito FC, J Pharmacol Sci 2013 [Epub ahead of print]
23. Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells. Chu JH, Wang H, Ye Y, Chan PK, Pan SY, Fong WF, Yu ZL, World J Gastroenterol 2011 17 19 2379 2388 10.3748/wjg.v17.i19.2379 21633637
24. Comparative analysis of bioactive component in seeds and flesh of Schisandrae chinensis Fructus by thin layer chromatography. Li LS, Shi WJ, Ma XB, Food Sci 2012 33 6 175 178
25. Determination of three organic acids in Schisandrae Chinensis Fructus by HPLC. Li L, Xiao Y, Yu D, Ma Y, Huang W, Tian G, Chen L, Chin J Chin Materia Med 2011 36 23 3286 3289
26. Dibenzocyclooctadiene lignans from the fruits of Schisandra wilsoniana and their anti-HIV-1 activities. Yang GY, Li YK, Wang RR, Xiao WL, Yang LM, Pu JX, Zheng YT, Sun HD, J Asian Nat Prod Res 2010 12 6 470 476 10.1080/10286020.2010.489823 20552486
27. Dibenzocyclooctadiene lignans and norlignans from fruits of Schisandra wilsoniana. Yang GY, Wang RR, Mu HX, Li YK, Li XN, Yang LM, Zheng YT, Xiao WL, Sun HD, J Nat Prod 2013 76 2 250 255 10.1021/np300745q 23327759
28. Low-density lipoprotein size and cardiovascular risk assessment. Rizzo M, Berneis K, QJM 2006 99 1 1 14 16371404
29. Friedewald-estimated versus directly measured low-density. Martin SS, Blaha MJ, Elshazly MB, Brinton EA, Toth PP, McEvoy JW, Joshi PH, Kulkarni KR, Mize PD, Kwiterovich PO, Defilippis AP, Blumenthal RS, Jones SR, J Am Coll Cardiol 2013 62 8 732 739 10.1016/j.jacc.2013.01.079 23524048
30. The relationship between subclinical atherosclerosis, non-high-density lipoprotein cholesterol, exercise, and diet among male participants of the PACC Project. Simprini LA, Villines TC, Rich M, Taylor AJ, J Clin Lipidol 2012 6 174 179 10.1016/j.jacl.2011.11.005 22385551
31. Non-HDL cholesterol vs. Apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study. Sondermeijer BM, Rana JS, Arsenault BJ, Shah PK, Kastelein JJ, Wareham NJ, Boekholdt SM, Khaw KT, Eur J Clin Invest 2013 doi: 10.1111/eci.12129
32. Non-high-density lipoprotein cholesterol and other risk factors of mild cognitive impairment among Chinese type 2 diabetic patients. Niu MJ, Yin FZ, Liu LX, Fang Y, Xuan XM, Wu GF, J Diabetes Complications 2013 doi:10.1016/j. jdiacomp
33. Insulin resistance in nonalcoholic fatty liver disease. Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G, Curr Pharm Des 2010 16 17 1941 1951 10.2174/138161210791208875 20370677
34. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosisand coronary heart disease. Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A, Nutrients 2013 5 5 1544 1560 10.3390/nu5051544 23666091
35. The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR-γ pathways in in vitro and in vivo studies. Kwon DY, da Kim S, Yang HJ, Park S, J Ethnopharmacol 2011 135 2 455 462 10.1016/j.jep.2011.03.037 21440615
36. Huang-Lian-Jie-Du-Tang supplemented with Schisandra chinensis Baill. and Polygonatum odoratum Druce improved glucose tolerance by potentiating insulinotropic actions in islets in 90% pancreatectomized diabetic rats. Park S, Hong SM, Ahn IS, Kim YJ, Lee JB, Biosci Biotechnol Biochem 2009 73 11 2384 2392 10.1271/bbb.90276 19897925
37. A novel experimental model of acute hypertriglyceridemia induced by schisandrin B. Pan SY, Dong H, Han YF, Li WY, Zhao XY, Ko KM, Eur J Pharmacol 2006 537 1-3 200 2044 16624278
38. A novel mouse model of combined hyperlipidemia associated with steatosis and liver injury by a single-dose intragastric administration of schisandrin B/cholesterol/bile salts mixture. Pan SY, Jia ZH, Zhang Y, Yu Q, Wang XY, Sun N, Zhu PL, Yu ZL, Ko KM, J Pharmacol Sci 2013 123 2 110 119 10.1254/jphs.13087FP 24096833
39. Effective kinetics of schisandrin B on serum/hepatic triglyceride and total cholesterol levels in mice with and without the influence of fenofibrate. Pan SY, Dong H, Guo BF, Zhang Y, Yu ZL, Fong WF, Han YF, Ko KM, Naunyn Schmiedebergs Arch Pharmacol 2011 383 6 585 591 10.1007/s00210-011-0634-x 21523558
40. High doses of bifendate elevate serum and hepatic triglyceride levels in rabbits and mice: animal models of acute hypertriglyceridemia. Pan SY, Yang R, Han YF, Dong H, Feng XD, Li N, Geng W, Ko KM, Acta Pharmacol Sin 2006 27 6 673 678 10.1111/j.1745-7254.2006.00332.x 16723084